Incontenance musk endorsement

Checked on December 15, 2025
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

This fact-check may be outdated. Consider refreshing it to get the most current information.

Executive summary

Reports based on a New York Times story say Elon Musk used multiple drugs, including ketamine, around the time he publicly endorsed Donald Trump in 2024 and that his ketamine use allegedly caused bladder problems such as incontinence (summarized in Rolling Stone and Futurism) [1] [2]. Popular outlets repeated the claim and linked ketamine’s known association with “ketamine bladder syndrome” — a clinical syndrome that can include frequency, pain, incontinence and blood in the urine — citing prior medical literature to explain the mechanism [2].

1. The core allegation: drug use coinciding with the endorsement

Several media outlets report that a New York Times piece described Musk as taking ketamine, MDMA (ecstasy), psilocybin mushrooms, Adderall and other pills during the period he endorsed President Trump in 2024; those accounts say Musk’s ketamine use was substantial enough to prompt complaints about bladder function [1] [2]. Rolling Stone frames this as Musk’s “frequent use of ketamine” during the 2024 campaign and says he “complained it was negatively affecting his bladder function” [1]. Futurism likewise states the reports placed bladder issues “around the time he publicly endorsed Trump in July” [2].

2. Medical context cited by reporting: what is “ketamine bladder”?

Reporting invoked existing medical literature on “ketamine bladder syndrome,” noting clinical features: a small, painful bladder, urinary frequency, incontinence, hematuria (blood in urine), and upper tract obstruction or kidney injury in chronic users [2]. Futurism referenced a 2012 study describing those outcomes and noted clinicians have observed rising bladder problems among younger ketamine users in some countries [2]. These medical descriptions are presented by outlets to explain how heavy ketamine use can plausibly produce urinary symptoms including incontinence [2].

3. How the story spread: mainstream and pop outlets

The narrative appeared in reporting summarized or amplified by outlets including Rolling Stone and Futurism, which both attribute the core details to a New York Times report and add context about medical risks [1] [2]. Lighter and opinion-driven sites — for example BroBible — extrapolated further and made more sensational claims about “peeing uncontrollably” at the time of the endorsement [3]. Media reaction included commentators expressing disgust or skepticism, as indicated by a linked CNN reaction page [4].

4. What the available sources do not establish

Available sources do not include the original New York Times article text within this packet, so direct quotes, sourcing details, or on-the-record confirmation from Musk or medical professionals specifically tied to his case are not present here — those elements are not found in current reporting provided (not found in current reporting). The provided summaries do not show direct medical records, timeline specifics beyond “around the time” of the endorsement, nor confirm whether symptoms persisted or were independently verified (not found in current reporting).

5. Competing perspectives and limitations in the coverage

Outlets differ in tone and in how strongly they characterize the claim: Rolling Stone and Futurism present the link between ketamine use and bladder problems as reported facts derived from the NYT summary [1] [2], while BroBible and some aggregated pieces push a punchier, more speculative line about uncontrollable urination [3]. CNN-linked coverage shows at least some media figures reacted with revulsion or skepticism, which indicates the claim provoked mixed responses [4]. The reporting relies on anonymous or unspecified sources summarized by other outlets; such sourcing limitations are implicit in the chain of reporting and reduce the ability to independently verify medical or behavioral claims [1] [2].

6. What to look for next: verification and context

To strengthen or rebut these claims, look for (a) the original New York Times reporting as published, including named sources and evidence; (b) any direct statement from Musk or his representatives responding to the medical and behavioral allegations; and (c) medical confirmation (with appropriate privacy protections) or reporting from clinicians who examined relevant records. None of those confirmations are present in the supplied results (not found in current reporting). Until such primary documentation appears, the story remains based on secondary summaries that cite medical literature to argue plausibility rather than providing direct clinical proof [2].

7. Bottom line for readers

Multiple outlets have reported that Musk’s ketamine use around his Trump endorsement was substantial enough to be linked to bladder problems, citing known medical risks of chronic ketamine use [1] [2]. The most sensational interpretations go beyond what the summarized reporting establishes; available sources in this bundle do not include the original NYT text or independent medical proof tied directly to Musk’s health, so the claim should be treated as reported and plausible on medical grounds but not fully independently verified here [1] [2].

Want to dive deeper?
Did Elon Musk publicly endorse any incontinence products or companies?
Has Elon Musk ever commented on healthcare or elderly care issues like incontinence?
Are there trademark or brand associations between Elon Musk and incontinence-related businesses?
How have Musk's endorsements historically affected small healthcare startups?
Could Musk's social media posts influence public perception of incontinence products or companies?